Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,197 | -16,530 | -10,956 | -5,506 | -6,275 |
| Depreciation Amortization | 77 | 38 | N/A | N/A | N/A |
| Other Working Capital | 2,668 | -617 | 514 | -581 | 1,537 |
| Other Operating Activity | 5,334 | 4,402 | 3,337 | 2,462 | 611 |
| Operating Cash Flow | $-16,119 | $-12,707 | $-7,106 | $-3,625 | $-4,127 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,249 | N/A | N/A | N/A | N/A |
| PPE Investments | -460 | -460 | N/A | N/A | N/A |
| Investing Cash Flow | $-40,709 | $-460 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 322 |
| Common Stock Issued | 99,002 | 98,809 | 97,766 | 32,336 | N/A |
| Financing Cash Flow | $99,002 | $98,809 | $97,766 | $32,336 | $322 |
| Beginning Cash Position | 2,025 | 2,025 | 2,025 | 2,025 | 5,830 |
| End Cash Position | 44,200 | 87,667 | 92,686 | 30,736 | 2,025 |
| Net Cash Flow | $42,175 | $85,642 | $90,661 | $28,711 | $-3,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,119 | -12,707 | -7,106 | -3,625 | -4,127 |
| Capital Expenditure | -460 | -460 | N/A | N/A | N/A |
| Free Cash Flow | -16,579 | -13,167 | -7,106 | -3,625 | -4,127 |